According to GlobalData’s medical device pipeline database, five Balloon Valvuloplasty Catheters devices are in various stages of development globally. GlobalData’s report Balloon Valvuloplasty Catheters provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.

Smarter leaders trust GlobalData

All five devices of this category are in active stage of development. There are three products in the early stages of development, and the remaining two are in the late stages of development.

Cardiovascular Devices are used to detect and treat heart and circulatory system related diseases. Balloon Valvuloplasty Catheters are used to treat the valve stenosis. Balloon Valvuloplasty Catheters replace or repair the damaged valves by inflating a balloon at the tip of the catheter. The inflated balloon presses against the valve, which widens the valve opening and improves blood flow.

Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.

Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Balloon Valvuloplasty Catheters pipeline devices are all expected to be approved within the next ten years.

Currently, private organizations, public entities and institutions are working on the development of Balloon Valvuloplasty Catheters devices. Overall, most of these Balloon Valvuloplasty Catheters pipeline devices are being developed by private entities.

Key players involved in the active development of Balloon Valvuloplasty Catheters include 3DT Holdings, NewMed Medical, OrbusNeich, Shanghai Healing Medical Instruments and Strait Access Technologies.

For a complete picture of the developmental pipeline for Balloon Valvuloplasty Catheters devices, buy the report here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. The Pipeline Products database is a is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.